Insights
Reports
Global Medical Cannabis Market Review
The Global Medical Cannabis Market Review examines the status and dynamics of the international medical cannabis supply chain, highlighting emerging developments and trends in key international markets. It provides country-specific data and analysis, comparing countr...
Poland Medical Cannabis Market Review (2025 Full Year Data & 2026-2027 Forecast)
A two-part package covering Poland's medical cannabis market through full-year 2025, with 2026–2027 forecasts:
1. Written report (PDF) — Professional market analysis with 7 data visualisations and several tables. Covers market size & growth, the te...
Relm Risk Briefing: Cannabis 2026
The global cannabis sector has moved from experiment to enterprise. What began as a patchwork of early medical markets now operates at international scale, shaped by regulation, investment, and public demand. Yet, as the industry matures, its exposure to operational,...
Data
Global Adult-Use Cannabis Market Sizing (excl. Europe) – 2022-2026
£649
Adult-use market sales projections for every country (excl. European countries) in which the products are legal. The market sizing package includes a raw datasheet of market sizing estimates for all regions up to 2026.
Countries featured:
North Americ...
Global Medical Cannabis Market Sizing (excl. Europe) – 2022-2026
£649
Medical cannabis market sales projections for every country (excl. European countries) in which the products are legal. The market sizing package includes a raw datasheet of market sizing estimates for all regions (excl. Europe) up to 2026. Countries featured...
Patent Portfolios
£699
This is a comprehensive review of the patent portfolios of Jazz Pharmaceuticals Ltd. (split into those held by GW Research Ltd., and those held by GW Pharmaceuticals Ltd.), and of six other leading companies involved in patenting activity for the medical appl...
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.